(Q48245475)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

title

In Situ shRNA Synthesis on DNA-Polylactide Nanoparticles to Treat Multidrug Resistant Breast Cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

main subject

multiple drug resistance

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Xiaoyuan Chen

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

3

Yunlei Zhang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Fuwu Zhang

2

1 reference

ORCID Public Data File 2021

author name string

Qianqian Ni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Zhe Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Zhaogang Teng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Chunyan Wang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Bryant C Yung

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Gang Niu

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Guangming Lu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

Longjiang Zhang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

language of work or name

English

0 references

publication date

15 January 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2012

9 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Drug resistance in cancer: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Nanopreparations to overcome multidrug resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Multidrug resistance: Physiological principles and nanomedical solutions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

In vivo RNA interference-mediated ablation of MDR1 P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Hyperbranched-hyperbranched polymeric nanoassembly to mediate controllable co-delivery of siRNA and drug for synergistic tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Nanoscale metal-organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Oligonucleotide-modified gold nanoparticles for intracellular gene regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Controlling DNA-nanoparticle serum interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

21 January 2018

Spherical nucleic acids

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Spherical nucleic acids as a divergent platform for synthesizing RNA-nanoparticle conjugates through enzymatic ligation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

First-in-humans trial of an RNA interference therapeutic targeting VEGF and KSP in cancer patients with liver involvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Biodegradable cationic polymeric nanocapsules for overcoming multidrug resistance and enabling drug-gene co-delivery to cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Blurring the Role of Oligonucleotides: Spherical Nucleic Acids as a Drug Delivery Vehicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

DNA block copolymers: functional materials for nanoscience and biomedicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Nucleic acid/organic polymer hybrid materials: synthesis, superstructures, and applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Enhanced growth inhibition of hepatic multicellular tumor spheroids by lactosylated poly(ethylene glycol)-siRNA conjugate formulated in PEGylated polyplexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Self-assembled RNA interference microsponges for efficient siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Design of a platform technology for systemic delivery of siRNA to tumours using rolling circle transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

PEGylation of cationic, shell-crosslinked-knedel-like nanoparticles modulates inflammation and enhances cellular uptake in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

PEGylation as a strategy for improving nanoparticle-based drug and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Therapeutic protein-polymer conjugates: advancing beyond PEGylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Supramolecular PEGylation of biopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Noncanonical self-assembly of multifunctional DNA nanoflowers for biomedical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

DNA-inorganic hybrid nanovaccine for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Drug resistance and the solid tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Cancer drug resistance: an evolving paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADMA.201705737

21 January 2018

Identifiers

DOI

10.1002/ADMA.201705737

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29333658%20AND%20SRC:MED&resulttype=core&format=json

9 April 2020

1 reference